Key facts
| Price (PPV) | 576 MAD |
|---|---|
| Dispensing status | Unscheduled — no prescription needed |
| Composition (DCI) | vaccin polysaccharidique contre les méningocoques ( sérogroupe aw-135 ) conjugé à l'anatoxine diphtérique |
| Class | Vaccines |
| ATC code | J07AH08 |
| Manufacturer | SANOFI AVENTIS MAROC |
| Presentation | Solution injectable boite de 1 flacons de 0,5 ml |
| Nature | Médicament |
| Hospital price | 383 MAD |
| Data collected on | 9/8/2026 |
Indications
Immunisation active des personnes âgées de 9 mois à 55 ans pour la prévention des maladies invasives à méningocoque causées par les sérogroupes A, C, Y et W-135 de N meningitidis.
Find an open pharmacy
On-call pharmacies near you
About Menactra 4 µg
Menactra 4 µg belongs to the vaccines therapeutic class. In Morocco, this drug is marketed by SANOFI AVENTIS MAROC and is among the pharmaceutical specialties referenced by the Ministry of Health.
For any question about the use, effects, or drug interactions of Menactra 4 µg, consult your doctor or pharmacist. This information is provided for educational purposes and does not replace medical advice.
Frequently Asked Questions about Menactra 4 µg
Answers to common questions from Moroccan patients about this drug.